Immuno-Oncology Innovation Award

Submit your abstract to apply for our travel award


Miltenyi Biotec is excited to honor researchers around the globe for their contributions to the immuno-oncology field. Innovative research will be awarded with travel, accommodation, and registration to selected immuno-oncology meetings. In addition, the winner will have the opportunity to share his or her research with the scientific community.

Check out the list of upcoming meetings that are covered by our Immuno-Oncology Innovation Award below and submit your abstract within the given timeline to apply for the award.

Upcoming meetings covered by our Immuno-Oncology Innovation Award*:

American Association for Cancer Research (AACR) Annual Meeting
March 30–April 03, 2019 | Atlanta, Georgia, USA

Abstract submission deadline: February 14, 2019
Travel award winner announcement: March 01, 2019

The 18th Meeting of the Society for Natural Immunity
September 30–October 03, 2019 | Luxembourg

Abstract submission deadline: August 16, 2019
Travel award winner announcement: September 01, 2019

*This contest is open for participation, at no charge, according to the respective deadlines.
Simply fill out the form at the end of this page to submit your abstract.

Check out what the winners of our previous travel awards have to say: 

Brian Koss 
University of Arkansas for Medical Sciences, Biochemistry and Molecular Biology, United States 

Winner of the 
Immuno-Oncology Innovation Award 2018 – American Association for Cancer Research (AACR) 

“The Chicago AACR meeting was an outstanding experience for me. I found the opportunity to interact with leaders in the field and to witness firsthand the excitement in cancer immunology to be extremely motivating. I am honored to have my work recognized by Miltenyi and would like to thank you for your dedication to innovation in immuno-oncology.”
Brian Koss is a Ph.D. student in the Tackett lab at the University of Arkansas for Medical Sciences. He specializes in the use of mass spectrometry for analysis of histone post-translational modifications. His current work focuses on defining epigenetic mechanisms driving metabolic exhaustion of tumor-infiltrating lymphocytes. 

Aurelien Colamartino
University of Montreal, CRCHU Sainte-Justine, Montreal

Winner of the
Immuno-Oncology Innovation Award 2018 –
The 17th Meeting of the Society for Natural Immunity

“The San Antonio NK meeting was a really great event to hear about the latest advances in science and a great opportunity to present my work. This award is also a good way to show Miltenyi’s interest in students’ projects. This travel grant allowed me to meet a lot of amazing scientists and to discuss my project and plans with them. I’m very grateful to Miltenyi for this opportunity.”

 Aurélien Colamartino is a Ph.D. student in the Haddad lab at the CRCHU Sainte-Justine in Montreal, Canada. His work focuses on a new, highly efficient transduction method to customize NK cells for immunotherapy, using different pseudotyped lentiviral particles.

Damya Laoui
Flanders Institute for Biotechnology, Vrije Universiteit Brussels

Winner of the
Immuno-Oncology Innovation Award 2018 –
15th International Symposium on Dendritic Cells

"I was very honored to receive the Immunology-Oncology Innovation Award, which gave me the opportunity to attend an excellent conference and to present my data. Miltenyi's commitment to support innovation and young scientists is a valuable strategy to move the onco-immunology field forward."

Damya Laoui, Ph.D., is a research scientist at the Vrije Universiteit Brussels and VIB in the lab of Jo Van Ginderacter. She graduated in Bio-Engineering Sciences and obtained a Ph.D. degree in 2014. After her post-doc in the De Palma lab at the ISREC Institute in the Ecole Polytechnique de Lausanne, she came back to Brussels where she leads her own team focusing on tumor-immunology. She is exploring the role of the immune system in tumor progression and is developing new personalized immunotherapies based on dendritic cells. For her work in tumor-immunology she received several prizes.

Constantine Bitsaktsis
Seton Hall University, South Orange

Winner of the
AAI Travel Award 2017

"My group has been using the MACSQuant® Flow Cytometer for our cancer peptide binding assays to identify the activation status of NK cells."

Constantine Bitsaktsis, Ph.D., is an Assistant Professor in the Department of Biological Sciences at Seton Hall University. He obtained his doctorate degree from King’s College University of London in 2002. He then moved state-side where he held two postdoctoral positions at the Wadsworth Center and the Albany Medical College in Albany, NY. His research is currently focusing on the utilization of novel vaccine approaches to combat microbial pathogens by generating long-term, protective immune responses.

Guobao Chen
John Hopkins University School of Medicine, Baltimore

Winner of the
AAI Travel Award 2017

"MACS® Microbeads for magnetic cell separation helped us to get 96.4% purity of a specific subset of cardiac fibroblasts out from the whole dissociated mouse heart cells."

Guobao Chen, Ph.D., is a Research Postdoctoral Fellow (Immunology Program), in the Department of Pathology at Johns Hopkins University School of Medicine. Dr. Chen received his doctoral degree in Immunology from National University of Singapore. His current project is focusing on the mechanism behind post-injury cardiac inflammation and remodeling.

Quirin Hammer
DRFZ, Berlin 

Winner of the
Immunology Travel Award 2016

"The Immunology Travel Award is a great opportunity for young scientists to participate in exciting scientific conferences. It shows Miltenyi Biotec's commitment to interaction within the field of immunology and is an excellent strategy to support early career immunologists.“

Quirin Hammer is currently a Ph.D. student in the Romagnani lab at the German Rheumatism-Research Center, Berlin. His general research interest lies in the field of regulation of innate lymphoid cell functions. His current research project focuses on natural killer (NK) cell memory during human cytomegalovirus (HCMV) infection.

Mélanie Durand
Institut Curie Research Center, Paris

Winner of the
Immunology Travel Award 2016

"The DC meeting 2016 was for me a unique opportunity in my Ph.D. to discuss with peers about my project but also about their project to have a larger view of the DC world. Thanks to Miltenyi Biotec's travel grant, I had a really amazing scientific time in Shanghai."

Mélanie Durand is currently a Ph.D. student in the Amigorena lab at the Institut Curie Research Center in Paris, France. Her research interest lies in the field of antigen presentation in dendritic cells and the molecular analysis of immune responses, particularly in the context of cancer.

Apply now – simply fill out the form below
We will process your personal data according to our privacy statement.

Immuno-oncology supported by Miltenyi Biotec

From basic research to innovative therapies

Click here to find our various immuno-oncology activities: Benefit from our experience, meet the experts, or share your research story.